| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 1.34e-04 | 11 | 191 | 3 | GO:0098505 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 2.30e-04 | 13 | 191 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 2.30e-04 | 13 | 191 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 2.30e-04 | 13 | 191 | 3 | GO:0043047 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 2.71e-04 | 3 | 191 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 3.60e-04 | 15 | 191 | 3 | GO:0098847 | |
| GeneOntologyBiologicalProcess | RNA localization | PRPF31 CASC3 FBL HNRNPA3 HNRNPA1L2 UPF3B THOC2 TERF1 HNRNPA1 ZNHIT3 IGF2BP3 | 4.88e-06 | 217 | 187 | 11 | GO:0006403 |
| GeneOntologyBiologicalProcess | snoRNA localization | 1.44e-05 | 6 | 187 | 3 | GO:0048254 | |
| GeneOntologyCellularComponent | microtubule organizing center | MPP1 TAPT1 CDH23 CCDC187 UPF3B ECPAS KIAA0753 CTAG2 CEP350 PJA2 MYOF RESF1 CEP95 DCTN6 ASPM ERCC6L2 MLF1 DYNC1LI1 PKN2 DIAPH3 PLK3 MTUS2 | 3.11e-05 | 919 | 189 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | MPP1 TAPT1 CDH23 CCDC187 UPF3B ECPAS KIAA0753 CTAG2 CEP350 PJA2 MYOF CEP95 DCTN6 ASPM ERCC6L2 DYNC1LI1 PKN2 PLK3 MTUS2 | 7.49e-05 | 770 | 189 | 19 | GO:0005813 |
| GeneOntologyCellularComponent | spliceosomal complex | PRPF31 CASC3 HNRNPA3 HNRNPA1L2 RBM48 CWC25 GPKOW HNRNPA1 HNRNPA1L3 | 1.54e-04 | 215 | 189 | 9 | GO:0005681 |
| GeneOntologyCellularComponent | core-binding factor complex | 2.42e-04 | 3 | 189 | 2 | GO:0016513 | |
| Domain | Runt | 9.10e-07 | 3 | 182 | 3 | PF00853 | |
| Domain | RUNT | 9.10e-07 | 3 | 182 | 3 | PS51062 | |
| Domain | TF_Runt-rel_RUNX | 9.10e-07 | 3 | 182 | 3 | IPR016554 | |
| Domain | RunxI | 9.10e-07 | 3 | 182 | 3 | PF08504 | |
| Domain | Runt_dom | 9.10e-07 | 3 | 182 | 3 | IPR013524 | |
| Domain | RunxI_C_dom | 9.10e-07 | 3 | 182 | 3 | IPR013711 | |
| Domain | Runx_central_dom | 9.10e-07 | 3 | 182 | 3 | IPR027384 | |
| Domain | - | 9.10e-07 | 3 | 182 | 3 | 4.10.770.10 | |
| Domain | AML1_Runt | 9.10e-07 | 3 | 182 | 3 | IPR000040 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.78e-05 | 6 | 182 | 3 | IPR012346 | |
| Domain | - | 1.78e-05 | 6 | 182 | 3 | 2.60.40.720 | |
| Domain | LA | 3.10e-05 | 7 | 182 | 3 | SM00715 | |
| Domain | HTH_LA | 3.10e-05 | 7 | 182 | 3 | PS50961 | |
| Domain | La | 3.10e-05 | 7 | 182 | 3 | PF05383 | |
| Domain | Lupus_La_RNA-bd | 3.10e-05 | 7 | 182 | 3 | IPR006630 | |
| Domain | DM15 | 9.44e-05 | 2 | 182 | 2 | SM00684 | |
| Domain | DM15 | 9.44e-05 | 2 | 182 | 2 | IPR006607 | |
| Domain | IQ | 1.40e-04 | 81 | 182 | 6 | SM00015 | |
| Domain | - | CPEB2 SETD1A REXO5 LARP6 HNRNPA3 HNRNPA1L2 UPF3B RBM48 HNRNPA1 IGF2BP3 | 1.45e-04 | 244 | 182 | 10 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | CPEB2 SETD1A REXO5 LARP6 HNRNPA3 HNRNPA1L2 UPF3B RBM48 HNRNPA1 IGF2BP3 | 2.27e-04 | 258 | 182 | 10 | IPR012677 |
| Domain | FA | 2.42e-04 | 13 | 182 | 3 | PF08736 | |
| Domain | FERM-adjacent | 2.42e-04 | 13 | 182 | 3 | IPR014847 | |
| Domain | FA | 2.42e-04 | 13 | 182 | 3 | SM01195 | |
| Domain | IQ_motif_EF-hand-BS | 2.49e-04 | 90 | 182 | 6 | IPR000048 | |
| Domain | HnRNPA1 | 2.82e-04 | 3 | 182 | 2 | IPR021662 | |
| Domain | HnRNPA1 | 2.82e-04 | 3 | 182 | 2 | PF11627 | |
| Domain | IQ | 2.98e-04 | 93 | 182 | 6 | PS50096 | |
| Domain | Nebulin | 5.59e-04 | 4 | 182 | 2 | PF00880 | |
| Domain | NEBULIN | 5.59e-04 | 4 | 182 | 2 | PS51216 | |
| Domain | DUF846 | 5.59e-04 | 4 | 182 | 2 | PF05832 | |
| Domain | NEBU | 5.59e-04 | 4 | 182 | 2 | SM00227 | |
| Domain | Nebulin | 5.59e-04 | 4 | 182 | 2 | IPR013998 | |
| Domain | DUF846_euk | 5.59e-04 | 4 | 182 | 2 | IPR008564 | |
| Domain | Nebulin_repeat | 5.59e-04 | 4 | 182 | 2 | IPR000900 | |
| Domain | IQ | 6.44e-04 | 71 | 182 | 5 | PF00612 | |
| Domain | Cadherin | 1.05e-03 | 118 | 182 | 6 | IPR002126 | |
| Domain | Ez/rad/moesin-like | 1.06e-03 | 21 | 182 | 3 | IPR000798 | |
| Domain | - | 1.17e-03 | 81 | 182 | 5 | 3.90.550.10 | |
| Domain | FERM_CS | 1.58e-03 | 24 | 182 | 3 | IPR019747 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CUL4A KIF13B PRPF31 DNAJB1 CASC3 PAK5 BAG3 PSD3 LARP1 LARP1B DENND1A KIAA0753 CEP350 KIAA1671 PJA2 USP8 RESF1 CEP95 PI4KB MACF1 LIMCH1 MAP4K4 EPB41L1 DNMT1 | 9.16e-11 | 861 | 192 | 24 | 36931259 |
| Pubmed | 1.52e-08 | 52 | 192 | 7 | 26265008 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CUL4A CASC3 MBTPS1 DNAJC13 SOBP HNRNPA3 OBSCN SREBF2 LARP1 MSH5 ECPAS DENND1A KIAA1671 IGF2 MYH14 PTPRR SBF2 LRRC27 PRKAG1 TVP23C MACF1 CHD6 ANKRD12 LIMCH1 UBE3C CUX1 EPB41L1 FRMD3 | 1.53e-08 | 1489 | 192 | 28 | 28611215 |
| Pubmed | KIF13B ELOA GHRL LARP6 STAG1 SMCHD1 HNRNPA3 DNAH2 LARP1 HNRNPA1L2 NEB TRDN HNRNPA1 SLC4A3 USP8 MYH14 DGKK ASPM MACF1 CHD6 LIMCH1 DIAPH3 DTHD1 RPL3L RPL4 CUX1 | 1.20e-07 | 1442 | 192 | 26 | 35575683 | |
| Pubmed | MPP1 PRPF31 CASC3 ELOA NEBL LARP1 ICE1 CWC25 GPKOW CEP350 USP8 GUCY1B1 MLF1 DYNC1LI1 CHD6 UBE3C MAP4K4 DNMT1 | 1.56e-07 | 733 | 192 | 18 | 34672954 | |
| Pubmed | 1.66e-07 | 3 | 192 | 3 | 7835892 | ||
| Pubmed | 1.66e-07 | 3 | 192 | 3 | 37525910 | ||
| Pubmed | Identification and comparative analysis of a second runx3 promoter. | 1.66e-07 | 3 | 192 | 3 | 11483356 | |
| Pubmed | Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development. | 1.66e-07 | 3 | 192 | 3 | 14516670 | |
| Pubmed | 1.66e-07 | 3 | 192 | 3 | 15713794 | ||
| Pubmed | Genetic regulation of the RUNX transcription factor family has antitumor effects. | 1.66e-07 | 3 | 192 | 3 | 28530640 | |
| Pubmed | DCHS2 LARP6 STAG1 ADGRB3 RUNX1 NDUFA10 TERF1 SLC4A3 SMYD2 CEP350 ZNF512B USP8 GUCY1B1 MYH14 CLK1 DCTN6 KCNJ6 MACF1 ALAD CHD6 MAP4K4 MTUS2 CUX1 DNMT1 | 2.04e-07 | 1285 | 192 | 24 | 35914814 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | PRPF31 ELOA OBSCN LARP1 HNRNPA1L2 UPF3B RFX1 HNRNPA1 PPM1B ASPM DTHD1 RPL4 | 2.21e-07 | 316 | 192 | 12 | 31665637 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PRPF31 CASC3 HIRIP3 FBL UPF3B MSH5 GPKOW DENND1A HNRNPA1 C2orf68 ZNHIT3 PPM1B CEP350 PJA2 PI4KB SBF2 AHR LIMCH1 DIAPH3 MAP4K4 RPL4 | 3.46e-07 | 1038 | 192 | 21 | 26673895 |
| Pubmed | MBTPS1 FRAS1 PSD3 CAMTA2 PJA2 USP8 SPHKAP MACF1 CHD6 ANKRD12 LIMCH1 UBE3C EPB41L1 | 4.93e-07 | 407 | 192 | 13 | 12693553 | |
| Pubmed | The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. | 6.60e-07 | 4 | 192 | 3 | 25185713 | |
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 12464175 | ||
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 33951764 | ||
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 20306685 | ||
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 12807883 | ||
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 20236534 | ||
| Pubmed | Central Role of Core Binding Factor β2 in Mucosa-Associated Lymphoid Tissue Organogenesis in Mouse. | 6.60e-07 | 4 | 192 | 3 | 26001080 | |
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 8437866 | ||
| Pubmed | 6.60e-07 | 4 | 192 | 3 | 29107070 | ||
| Pubmed | A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. | 6.60e-07 | 4 | 192 | 3 | 10228168 | |
| Pubmed | DNAJB1 FRAS1 DNAJC13 TAPT1 TMEM237 BAG3 PSD3 COLGALT1 HNRNPA1 NCAPG2 KIAA0753 ZNF512B MRPS10 PJA2 MAP4K5 ASPM MACF1 PKN2 DIAPH3 MAP4K4 EIF2AK3 RPL4 CUX1 EPB41L1 DNMT1 | 7.77e-07 | 1487 | 192 | 25 | 33957083 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | DNAJB1 ELOA NEBL SMCHD1 BAG3 LARP1 ICE1 UPF3B THOC2 GPKOW HNRNPA1 ZNF512B KIAA1671 USP8 IGF2BP3 MACF1 PKN2 RPL4 DNMT1 | 1.19e-06 | 934 | 192 | 19 | 33916271 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPF1 PRPF31 ELOA DNAJC13 FBL SMCHD1 HNRNPA3 LARP1 UPF3B THOC2 TERF1 IGF2BP3 ASPM MACF1 UBE3C RPL4 DNMT1 | 1.23e-06 | 759 | 192 | 17 | 35915203 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL4A KIF13B PRPF31 DNAJB1 ELOA DNAJC13 PITRM1 TMEM237 BAG3 LARP1 CDH23 NDUFA10 CWC25 RFX1 DENND1A NCAPG2 SMYD2 KIAA1671 USP8 DCTN6 PI4KB MLF1 DYNC1LI1 | 1.24e-06 | 1321 | 192 | 23 | 27173435 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4A PRPF31 ELOA SMCHD1 HNRNPA3 LARP1 ICE1 HNRNPA1L2 NDUFA10 THOC2 CWC25 RFX1 GPKOW HNRNPA1 ZNF512B NUTM2B SIMC1 CUX1 DNMT1 | 1.63e-06 | 954 | 192 | 19 | 36373674 |
| Pubmed | Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome. | 1.64e-06 | 5 | 192 | 3 | 24797007 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 35114276 | ||
| Pubmed | Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma. | 1.64e-06 | 5 | 192 | 3 | 34803166 | |
| Pubmed | 1.64e-06 | 5 | 192 | 3 | 9794229 | ||
| Pubmed | Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. | 1.64e-06 | 5 | 192 | 3 | 17377532 | |
| Pubmed | Interplay between SOX7 and RUNX1 regulates hemogenic endothelial fate in the yolk sac. | 1.64e-06 | 5 | 192 | 3 | 27802172 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.03e-06 | 202 | 192 | 9 | 33005030 | |
| Pubmed | CASC3 ELOA TMEM237 FBL SMCHD1 PCDHAC2 LARP1 UPF3B LARP1B NDUFA10 THOC2 CWC25 GPKOW DENND1A C2orf68 CEP350 MRPS10 IGF2BP3 MYH14 AHR LIMCH1 MGME1 DNMT1 | 2.31e-06 | 1371 | 192 | 23 | 36244648 | |
| Pubmed | DNAJB1 SETD1A FBL SMCHD1 BAG3 LARP1 THOC2 RFX1 KIAA1671 PKN2 DIAPH3 MAP4K4 CUX1 DNMT1 | 2.54e-06 | 549 | 192 | 14 | 38280479 | |
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 24677539 | ||
| Pubmed | The essential requirement for Runx1 in the development of the sternum. | 3.27e-06 | 6 | 192 | 3 | 20152828 | |
| Pubmed | Stella is a maternal effect gene required for normal early development in mice. | 3.27e-06 | 6 | 192 | 3 | 14654002 | |
| Pubmed | 3.27e-06 | 6 | 192 | 3 | 23532528 | ||
| Pubmed | PAK5 BAG3 SREBF2 NEB TERF1 CEP350 CEP95 MAP4K5 SIMC1 MACF1 CHD6 MAP4K4 CUX1 | 3.50e-06 | 486 | 192 | 13 | 20936779 | |
| Pubmed | 3.50e-06 | 114 | 192 | 7 | 31553912 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MPP1 PRPF31 DCHS2 OBSCN PCDHB6 CCDC187 NEB ECPAS TRANK1 ERCC6L2 FGB LIMCH1 MAP4K4 | 4.45e-06 | 497 | 192 | 13 | 36774506 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSP90B2P HNRNPA3 DNAH2 ADGRB3 HNRNPA1L2 UPF3B THOC2 HNRNPA1 IGF2BP3 MYH14 GALNTL5 DYNC1LI1 MACF1 MAP4K4 RPL3L RPL4 DNMT1 | 5.32e-06 | 847 | 192 | 17 | 35235311 |
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 20181744 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 1497882 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 18759297 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 16962269 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 21088106 | ||
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 24505141 | ||
| Pubmed | Physical and functional link of the leukemia-associated factors AML1 and PML. | 5.70e-06 | 7 | 192 | 3 | 15331439 | |
| Pubmed | Comparative proteomic analysis to study molecular events during gonad development in mice. | 5.70e-06 | 7 | 192 | 3 | 16604525 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DNAJC13 SMCHD1 BAG3 HNRNPA3 CDH23 ICE1 UPF3B HNRNPA1 CLK1 CEP95 MACF1 | 5.95e-06 | 361 | 192 | 11 | 26167880 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 ELOA DNAJC13 HIRIP3 BAG3 LARP1 RUNX1 ECPAS THOC2 RFX1 MYOF DYNC1LI1 PKN2 LIMCH1 MAP4K4 DNMT1 | 7.06e-06 | 774 | 192 | 16 | 15302935 |
| Pubmed | DNAJC13 FBL HNRNPA3 LARP1 COLGALT1 HNRNPA1 IGF2BP3 MYH14 SBF2 PRKAG1 MACF1 MAP4K4 RPL4 DNMT1 | 7.14e-06 | 601 | 192 | 14 | 33658012 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DNAJB1 TAPT1 PITRM1 TMEM237 SMCHD1 BAG3 PCDHAC2 NDUFA10 NCAPG2 USP8 MYOF AHR FGB TVP23C DYNC1LI1 MACF1 UBE3C CSGALNACT1 CUX1 | 7.47e-06 | 1061 | 192 | 19 | 33845483 |
| Pubmed | Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis. | 8.77e-06 | 24 | 192 | 4 | 15136142 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | MPP1 SPRY1 TMEM237 PSD3 MYOF ABI2 PLEKHO2 MAP4K5 PKN2 MAP4K4 EPB41L1 | 8.94e-06 | 377 | 192 | 11 | 38117590 |
| Pubmed | 9.09e-06 | 8 | 192 | 3 | 10531362 | ||
| Pubmed | Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects. | 9.09e-06 | 8 | 192 | 3 | 21807129 | |
| Pubmed | Dominance of SOX9 function over RUNX2 during skeletogenesis. | 9.09e-06 | 8 | 192 | 3 | 17142326 | |
| Pubmed | 9.09e-06 | 8 | 192 | 3 | 16545802 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CUL4A PRPF31 DNAJB1 FBL SMCHD1 BAG3 HNRNPA3 LARP1 UPF3B COLGALT1 HNRNPA1 YARS2 MRPS10 MLKL USP8 IGF2BP3 PRKAG1 MACF1 PKN2 DIAPH3 RPL4 DNMT1 | 1.28e-05 | 1415 | 192 | 22 | 28515276 |
| Pubmed | PRPF31 DNAJB1 SMCHD1 HNRNPA3 LARP1 UPF3B RUNX2 RUNX1 ECPAS THOC2 RFX1 HNRNPA1 NCAPG2 MLKL IGF2BP3 RESF1 DYNC1LI1 CUX1 DNMT1 | 1.29e-05 | 1103 | 192 | 19 | 34189442 | |
| Pubmed | CPEB2 RPF1 KIF13B PRPF31 FBL SMCHD1 HNRNPA3 LARP1 HNRNPA1L2 LARP1B DENND1A HNRNPA1 IGF2BP3 CLK1 RPL4 | 1.32e-05 | 723 | 192 | 15 | 34133714 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | MPP1 RPF1 DNAJC13 COLGALT1 NDUFA10 KIAA1671 PJA2 MAP4K5 FAM222B SIMC1 | 1.35e-05 | 322 | 192 | 10 | 39098523 |
| Pubmed | Runx1 contributes to neurofibromatosis type 1 neurofibroma formation. | 1.36e-05 | 9 | 192 | 3 | 26073082 | |
| Pubmed | 1.36e-05 | 9 | 192 | 3 | 19339464 | ||
| Pubmed | A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. | 1.51e-05 | 95 | 192 | 6 | 37211047 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CASC3 SETD1A ELOA MBTPS1 SMCHD1 HNRNPA3 LARP1 COLGALT1 GPKOW HNRNPA1 ZNHIT3 ZNF512B PJA2 IGF2BP3 GUCY1B1 DYNC1LI1 DNMT1 | 1.59e-05 | 922 | 192 | 17 | 27609421 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 SETD1A DNAJC13 FBL SMCHD1 BAG3 HNRNPA3 HIP1R COLGALT1 RUNX1 HNRNPA1 NCAPG2 PLCD3 MYH14 MAP4K5 ASPM DYNC1LI1 MACF1 PKN2 RPL4 DNMT1 | 2.10e-05 | 1353 | 192 | 21 | 29467282 |
| Pubmed | CUL4A NEBL FBL BAG3 HNRNPA3 LARP1 UPF3B RUNX2 RUNX1 NDUFA10 THOC2 HNRNPA1 PPM1B MYOF IGF2BP3 MYH14 AHR LIMCH1 RPL4 CUX1 | 2.10e-05 | 1247 | 192 | 20 | 27684187 | |
| Pubmed | 2.31e-05 | 152 | 192 | 7 | 34299191 | ||
| Pubmed | DNAJC13 BAG3 ICE1 ECPAS NDUFA10 RFX1 KIAA1671 RESF1 CHD6 DIAPH3 CUX1 | 2.32e-05 | 418 | 192 | 11 | 34709266 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DNAJB1 ELOA SMCHD1 LARP1 NDUFA10 GPKOW HNRNPA1 CEP350 MYH14 ASPM GALNTL5 UBE3C MAP4K4 CUX1 | 2.39e-05 | 670 | 192 | 14 | 22990118 |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 32960212 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 9233771 | ||
| Pubmed | Using thermal scanning assays to test protein-protein interactions of inner-ear cadherins. | 3.03e-05 | 2 | 192 | 2 | 29261728 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 30864186 | ||
| Pubmed | Expression patterns and prognostic value of RUNX genes in kidney cancer. | 3.03e-05 | 2 | 192 | 2 | 34294773 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 19403666 | ||
| Pubmed | The extracellular loop of pendrin and prestin modulates their voltage-sensing property. | 3.03e-05 | 2 | 192 | 2 | 29777056 | |
| Pubmed | Identification of sequence variants influencing immunoglobulin levels. | 3.03e-05 | 2 | 192 | 2 | 28628107 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 21940737 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 9139737 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 15537665 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 15525641 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 12403780 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 26883634 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 32239963 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 19851499 | ||
| Pubmed | Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. | 3.03e-05 | 2 | 192 | 2 | 16059634 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 32835555 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 12560094 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 37919525 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 17240369 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 1406633 | ||
| Interaction | FCMR interactions | 2.96e-08 | 11 | 188 | 5 | int:FCMR | |
| Interaction | EPX interactions | 2.69e-07 | 16 | 188 | 5 | int:EPX | |
| Interaction | OR9Q2 interactions | 7.88e-06 | 5 | 188 | 3 | int:OR9Q2 | |
| Interaction | YWHAG interactions | CUL4A KIF13B DNAJB1 CASC3 PAK5 BAG3 PSD3 LARP1 LARP1B TERF1 DENND1A DPPA3 KIAA0753 CEP350 KIAA1671 PJA2 USP8 CLK1 CEP95 MAP4K5 PI4KB SIMC1 MACF1 PKN2 MAP4K4 FRMD5 EPB41L1 DNMT1 | 1.40e-05 | 1248 | 188 | 28 | int:YWHAG |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 8.39e-06 | 7 | 114 | 3 | 625 | |
| GeneFamily | Cadherin related | 1.56e-04 | 17 | 114 | 3 | 24 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 3.89e-04 | 5 | 114 | 2 | 655 | |
| GeneFamily | RNA binding motif containing | 4.05e-04 | 213 | 114 | 7 | 725 | |
| GeneFamily | Ferlin family | 5.81e-04 | 6 | 114 | 2 | 828 | |
| GeneFamily | Actins|Deafness associated genes | 7.45e-04 | 113 | 114 | 5 | 1152 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | DNAJB1 LARP6 MTHFD2 BAG3 CAMTA2 UPF3B TVP23B RBM48 PJA2 RESF1 CLK1 PLEKHO2 MAP4K5 MLF1 AHR DYNC1LI1 FGF2 ANKRD12 EIF2AK3 PLK3 CUX1 | 7.42e-07 | 822 | 192 | 21 | M6782 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | MPP1 BEND5 DNAH2 ADGRB3 PSD3 SCRN1 RUNX2 LHX8 RUNX1 RUNX3 ZNF512B MYOF MYH14 FAM222B DGKK PCDH15 AHR FGF2 HAND1 PLK3 MTUS2 EPB41L1 FRMD3 | 1.48e-05 | 967 | 187 | 23 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | SOBP SLC26A5 DNAH2 LHX8 MYOF MYH14 PCDH15 FGF2 MACF1 MTUS2 EPB41L1 | 3.54e-05 | 276 | 187 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | SOBP SLC26A5 DNAH2 PSD3 SCRN1 LHX8 RUNX1 THOC2 MYOF MYH14 FAM222B DGKK SIMC1 PCDH15 AHR FGF2 MACF1 HAND1 LIMCH1 MTUS2 EPB41L1 FRMD3 | 5.30e-05 | 978 | 187 | 22 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRAS1 COL12A1 OBSCN ODAD2 NEB TRDN FREM1 TRANK1 DGKK PCDH15 DNAH11 | 5.10e-10 | 184 | 192 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRAS1 COL12A1 OBSCN ODAD2 NEB TRDN FREM1 TRANK1 DGKK PCDH15 DNAH11 | 5.10e-10 | 184 | 192 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRAS1 COL12A1 OBSCN ODAD2 NEB TRDN FREM1 TRANK1 DGKK PCDH15 DNAH11 | 5.10e-10 | 184 | 192 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | NEBL OBSCN PSD3 TRDN SLC4A3 SPHKAP LIMCH1 B4GALNT3 RPL3L CSGALNACT1 MTUS2 | 7.17e-10 | 190 | 192 | 11 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | NEBL OBSCN TRDN SMYD2 PEBP4 SPHKAP B4GALNT3 RPL3L CSGALNACT1 MTUS2 | 9.29e-09 | 187 | 192 | 10 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | NEBL OBSCN TRDN SMYD2 PEBP4 SPHKAP LIMCH1 B4GALNT3 RPL3L MTUS2 | 9.78e-09 | 188 | 192 | 10 | 0758b474457efa36488e0195f7357100f4b6a090 |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | NEBL OBSCN TRDN PEBP4 SPHKAP MLF1 B4GALNT3 RPL3L CSGALNACT1 MTUS2 | 1.03e-08 | 189 | 192 | 10 | 9c1debd65c13d63fd4f3158917d621b44b714c26 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | NEBL OBSCN TRDN SMYD2 SPHKAP LIMCH1 B4GALNT3 RPL3L CSGALNACT1 MTUS2 | 1.03e-08 | 189 | 192 | 10 | 5e80c47f63980904c4c1ff02c201b67b456a0974 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | NEBL OBSCN PSD3 TRDN PEBP4 SPHKAP LIMCH1 B4GALNT3 RPL3L MTUS2 | 1.08e-08 | 190 | 192 | 10 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | NEBL OBSCN TRDN SMYD2 PEBP4 SPHKAP MLF1 LIMCH1 B4GALNT3 MTUS2 | 1.20e-08 | 192 | 192 | 10 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.54e-07 | 191 | 192 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-07 | 191 | 192 | 9 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.54e-07 | 191 | 192 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-07 | 191 | 192 | 9 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.75e-07 | 194 | 192 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.75e-07 | 194 | 192 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.00e-07 | 197 | 192 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Caecum-T_cell-Th1|T_cell / Region, Cell class and subclass | 2.17e-07 | 199 | 192 | 9 | 13a80e6d3cf9c831edbe0644545071153e35f82b | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 172 | 192 | 8 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 172 | 192 | 8 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.05e-06 | 177 | 192 | 8 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.46e-06 | 185 | 192 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 186 | 192 | 8 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 187 | 192 | 8 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 187 | 192 | 8 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-06 | 190 | 192 | 8 | 373629dde5eda722424c5e6087763f0c5db67cf4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.92e-06 | 192 | 192 | 8 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 193 | 192 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.16e-06 | 195 | 192 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.16e-06 | 195 | 192 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | control-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.33e-06 | 197 | 192 | 8 | cdb2866d5a8fbf39847309124479ad49c88852d4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 199 | 192 | 8 | bb201deb281619113edcd1de2af2d3eb21b967b8 | |
| ToppCell | AT1_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.58e-06 | 90 | 192 | 6 | 6cbf30dd3992d8ccfaa74ad9781b9f8735f1ef69 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.60e-06 | 200 | 192 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 2.60e-06 | 200 | 192 | 8 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-06 | 152 | 192 | 7 | 655d47efe0608d729801f1f01668e84c1bc0675f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 160 | 192 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-06 | 160 | 192 | 7 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-06 | 160 | 192 | 7 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 160 | 192 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-06 | 169 | 192 | 7 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.23e-06 | 170 | 192 | 7 | bda900c836e0f2c1d7b442beb50b672d025b2420 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 170 | 192 | 7 | 28fb192b21cdc5a77ba4f276694cff852eb2304b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 170 | 192 | 7 | 239cb4b801b2d71a6facb386f2684c0851504151 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.59e-06 | 171 | 192 | 7 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.96e-06 | 172 | 192 | 7 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 178 | 192 | 7 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 180 | 192 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.34e-05 | 180 | 192 | 7 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.49e-05 | 183 | 192 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 184 | 192 | 7 | 72b42dfca7e9c0257f11d8242531e843271871a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 184 | 192 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 184 | 192 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 184 | 192 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 184 | 192 | 7 | c6f4537ae8b6e8fde1be17df14629b7b49b4997c | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 184 | 192 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 185 | 192 | 7 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-05 | 186 | 192 | 7 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.65e-05 | 186 | 192 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 187 | 192 | 7 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 187 | 192 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.77e-05 | 188 | 192 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.77e-05 | 188 | 192 | 7 | 3e94d105ca96ceb5fdcca39a8050217913bc02da | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 188 | 192 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.83e-05 | 189 | 192 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 189 | 192 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 191 | 192 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 192 | 192 | 7 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 192 | 192 | 7 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.03e-05 | 192 | 192 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.03e-05 | 192 | 192 | 7 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 192 | 192 | 7 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-05 | 193 | 192 | 7 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-05 | 193 | 192 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-05 | 193 | 192 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-05 | 194 | 192 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.17e-05 | 194 | 192 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 194 | 192 | 7 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 194 | 192 | 7 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-05 | 194 | 192 | 7 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 195 | 192 | 7 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-05 | 195 | 192 | 7 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 195 | 192 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | severe-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.24e-05 | 195 | 192 | 7 | 5badcfdeed2fb7453a9c144506ca91c5475cd35f | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.32e-05 | 196 | 192 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 2.39e-05 | 197 | 192 | 7 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 197 | 192 | 7 | 0b2ad6a933ff1a325649cc8f139380fd158a1d42 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 197 | 192 | 7 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.39e-05 | 197 | 192 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.47e-05 | 198 | 192 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 198 | 192 | 7 | a14d16d4755bd523d66e3b55e7d78cbb5359acfc | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 199 | 192 | 7 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.64e-05 | 200 | 192 | 7 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.64e-05 | 200 | 192 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-dn_T|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.64e-05 | 200 | 192 | 7 | 1aa298dd7172e023adf569c32e49f69fa8d9c7ff | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.64e-05 | 200 | 192 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.13e-05 | 139 | 192 | 6 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.97e-05 | 145 | 192 | 6 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 4.13e-05 | 146 | 192 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.62e-05 | 149 | 192 | 6 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HG-U133A | PRPF31 NEBL STAG1 PPM1B YARS2 USP8 IGF2BP3 MYH14 PLEKHO2 MAP4K5 AHR | 1.01e-06 | 200 | 190 | 11 | 1914_DN |
| Disease | stomach cancer (is_marker_for) | 3.09e-05 | 142 | 183 | 7 | DOID:10534 (is_marker_for) | |
| Disease | Usher syndrome, type 1D | 3.83e-05 | 2 | 183 | 2 | C2931208 | |
| Disease | USHER SYNDROME, TYPE ID | 3.83e-05 | 2 | 183 | 2 | C1832845 | |
| Disease | USHER SYNDROME, TYPE ID | 3.83e-05 | 2 | 183 | 2 | 601067 | |
| Disease | Usher syndrome type 1D | 3.83e-05 | 2 | 183 | 2 | cv:C1832845 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 3.83e-05 | 2 | 183 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | neurodevelopmental disorder with eye movement abnormalities and ataxia (implicated_via_orthology) | 3.83e-05 | 2 | 183 | 2 | DOID:0081275 (implicated_via_orthology) | |
| Disease | ovary epithelial cancer (is_marker_for) | 6.41e-05 | 13 | 183 | 3 | DOID:2152 (is_marker_for) | |
| Disease | Nonsyndromic genetic hearing loss | 1.12e-04 | 76 | 183 | 5 | cv:C5680182 | |
| Disease | tumor necrosis factor receptor superfamily member 1B measurement | 1.14e-04 | 3 | 183 | 2 | EFO_0010624 | |
| Disease | Nerve Degeneration | 1.71e-04 | 83 | 183 | 5 | C0027746 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.86e-04 | 189 | 183 | 7 | EFO_0009932 | |
| Disease | myopathy (implicated_via_orthology) | 2.25e-04 | 48 | 183 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Fraser syndrome (implicated_via_orthology) | 2.28e-04 | 4 | 183 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | Inherited acute myeloid leukemia | 2.28e-04 | 4 | 183 | 2 | C4707228 | |
| Disease | apolipoprotein B measurement | KIF13B DCHS2 DNAJC13 STAG1 PSD3 USP8 MYOF MAP4K5 FER1L4 FGB DYNC1LI1 B4GALNT3 DNAH11 | 2.72e-04 | 663 | 183 | 13 | EFO_0004615 |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.85e-04 | 51 | 183 | 4 | cv:CN043650 | |
| Disease | Hereditary hearing loss and deafness | 3.10e-04 | 146 | 183 | 6 | cv:C0236038 | |
| Disease | hearing impairment | 3.70e-04 | 98 | 183 | 5 | C1384666 | |
| Disease | Usher syndrome, type 1A | 3.78e-04 | 5 | 183 | 2 | C2931205 | |
| Disease | prenatal alcohol exposure | 3.78e-04 | 5 | 183 | 2 | C0678807 | |
| Disease | Pituitary-dependent Cushing's disease | 3.78e-04 | 5 | 183 | 2 | C0221406 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 3.78e-04 | 5 | 183 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 3.78e-04 | 5 | 183 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 3.78e-04 | 5 | 183 | 2 | C1848640 | |
| Disease | 2-hydroxydecanoate measurement | 3.78e-04 | 5 | 183 | 2 | EFO_0800347 | |
| Disease | Usher syndrome type 1 | 3.78e-04 | 5 | 183 | 2 | cv:C1568247 | |
| Disease | sleep duration, triglyceride measurement | 4.86e-04 | 104 | 183 | 5 | EFO_0004530, EFO_0005271 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 4.88e-04 | 25 | 183 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | CUL4A GAD1 DCHS2 PSD3 CCDC168 THOC2 HNRNPA1L3 SMYD2 IGF2BP3 TRANK1 MAP4K5 KCNJ6 SPHKAP PCDH15 MACF1 MAP4K4 CUX1 DNAH11 | 5.39e-04 | 1206 | 183 | 18 | EFO_0004458 |
| Disease | Clear cell sarcoma of kidney | 5.65e-04 | 6 | 183 | 2 | C0334488 | |
| Disease | Cushing Syndrome | 5.65e-04 | 6 | 183 | 2 | C0010481 | |
| Disease | N1-methyladenosine measurement | 5.65e-04 | 6 | 183 | 2 | EFO_0021122 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 5.65e-04 | 6 | 183 | 2 | DOID:0110306 (implicated_via_orthology) | |
| Disease | Pituitary Gland Adenoma | 5.65e-04 | 6 | 183 | 2 | EFO_1000478 | |
| Disease | Usher Syndrome, Type I | 5.65e-04 | 6 | 183 | 2 | C1568247 | |
| Disease | white matter hyperintensity measurement | 6.26e-04 | 302 | 183 | 8 | EFO_0005665 | |
| Disease | Hereditary retinal dystrophy | 7.87e-04 | 7 | 183 | 2 | C0154860 | |
| Disease | Usher syndrome | 7.87e-04 | 7 | 183 | 2 | cv:C0271097 | |
| Disease | acquired immunodeficiency syndrome (is_marker_for) | 7.87e-04 | 7 | 183 | 2 | DOID:635 (is_marker_for) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 7.87e-04 | 7 | 183 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma | 8.09e-04 | 67 | 183 | 4 | EFO_0000707 | |
| Disease | right ventricular ejection fraction measurement | 8.42e-04 | 30 | 183 | 3 | EFO_0021816 | |
| Disease | DNA methylation | DCHS2 NEBL RUNX1 HNRNPA1L3 FREM1 IGF2 RESF1 MAP4K5 AHR HAND1 MTUS2 DNAH11 | 8.56e-04 | 656 | 183 | 12 | GO_0006306 |
| Disease | skin aging measurement | 9.61e-04 | 181 | 183 | 6 | EFO_0008006 | |
| Disease | testosterone measurement | FOXM1 GALNT15 CASC3 DCHS2 STAG1 DNAH2 PSD3 AS3MT ZNHIT3 KIAA0753 IGF2 MAP4K5 SBF2 DGKK UGT2B10 MACF1 HS3ST4 FRMD5 | 1.02e-03 | 1275 | 183 | 18 | EFO_0004908 |
| Disease | Unilateral agenesis of kidney | 1.05e-03 | 8 | 183 | 2 | C0266294 | |
| Disease | Borderline personality disorder | 1.33e-03 | 35 | 183 | 3 | HP_0012076 | |
| Disease | endometrial cancer (is_marker_for) | 1.33e-03 | 35 | 183 | 3 | DOID:1380 (is_marker_for) | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 1.34e-03 | 9 | 183 | 2 | OBA_2045190 | |
| Disease | Nonsyndromic Deafness | 1.64e-03 | 81 | 183 | 4 | C3711374 | |
| Disease | Bone Resorption | 1.67e-03 | 10 | 183 | 2 | C0005974 | |
| Disease | Joubert syndrome (is_implicated_in) | 1.67e-03 | 10 | 183 | 2 | DOID:0050777 (is_implicated_in) | |
| Disease | urinary 6‑hydroxymelatonin sulfate to creatinine ratio | 1.67e-03 | 10 | 183 | 2 | EFO_0021488 | |
| Disease | urate measurement, bone density | FRAS1 SLC26A5 ADGRB3 PSD3 RUNX1 DENND1A FREM1 PEBP4 MAP4K5 ARHGAP25 DNAH11 | 1.76e-03 | 619 | 183 | 11 | EFO_0003923, EFO_0004531 |
| Disease | kynurenine measurement | 1.82e-03 | 39 | 183 | 3 | EFO_0008529 | |
| Disease | personality trait | 1.82e-03 | 39 | 183 | 3 | EFO_0004365 | |
| Disease | obsolete_red blood cell distribution width | CUL4A DNAJC13 HIP1R AS3MT LARP1 CDH23 RUNX1 HNRNPA1 ZNHIT3 RESF1 MAP4K5 FAM222B SIMC1 PRKAG1 UGT2B10 PKN2 ANKRD12 FRMD5 | 1.87e-03 | 1347 | 183 | 18 | EFO_0005192 |
| Disease | Parkinsonism (is_implicated_in) | 2.03e-03 | 11 | 183 | 2 | DOID:0080855 (is_implicated_in) | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 2.03e-03 | 11 | 183 | 2 | EFO_0009923 | |
| Disease | 1-methylxanthine measurement | 2.03e-03 | 11 | 183 | 2 | EFO_0021174 | |
| Disease | X-18913 measurement | 2.03e-03 | 11 | 183 | 2 | EFO_0800795 | |
| Disease | Disorder of eye | 2.15e-03 | 212 | 183 | 6 | C0015397 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.15e-03 | 145 | 183 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | left ventricular structural measurement | 2.23e-03 | 88 | 183 | 4 | EFO_0008205 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 2.42e-03 | 90 | 183 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.89e-03 | 225 | 183 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 3.11e-03 | 47 | 183 | 3 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.31e-03 | 14 | 183 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | diabetic neuropathy (is_implicated_in) | 3.31e-03 | 14 | 183 | 2 | DOID:9743 (is_implicated_in) | |
| Disease | Birth Weight | 3.31e-03 | 14 | 183 | 2 | C0005612 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 3.81e-03 | 15 | 183 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 3.81e-03 | 15 | 183 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | anemia (implicated_via_orthology) | 3.81e-03 | 15 | 183 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | CUL4A DNAJC13 PSD3 LARP1 RUNX1 NEB HNRNPA1 PPM1B MAP4K5 FAM222B UGT2B10 MACF1 PKN2 ANKRD12 UBE3C | 3.85e-03 | 1105 | 183 | 15 | EFO_0004528 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.88e-03 | 239 | 183 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 3.93e-03 | 51 | 183 | 3 | EFO_0022302 | |
| Disease | Liver Cirrhosis | 3.93e-03 | 103 | 183 | 4 | C0023890 | |
| Disease | complement factor H-related protein 3 measurement | 4.15e-03 | 169 | 183 | 5 | EFO_0600056 | |
| Disease | Fibrosis, Liver | 4.21e-03 | 105 | 183 | 4 | C0239946 | |
| Disease | FEV/FEC ratio | DCHS2 FRAS1 NEBL BAG3 CDH23 RUNX2 NEB RUNX3 PPM1B USP8 TP53TG5 PLEKHO2 SBF2 ERCC6L2 DTHD1 CUX1 | 4.24e-03 | 1228 | 183 | 16 | EFO_0004713 |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 4.34e-03 | 16 | 183 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | coffee consumption, cups of coffee per day measurement | 4.34e-03 | 16 | 183 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | interleukin 1 receptor antagonist measurement | 4.38e-03 | 53 | 183 | 3 | EFO_0004754 | |
| Disease | response to antidepressant | 4.92e-03 | 176 | 183 | 5 | GO_0036276 | |
| Disease | Ciliopathies | 4.96e-03 | 110 | 183 | 4 | C4277690 | |
| Disease | urinary albumin to creatinine ratio | 5.28e-03 | 179 | 183 | 5 | EFO_0007778 | |
| Disease | Prostatic Neoplasms | 5.30e-03 | 616 | 183 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.30e-03 | 616 | 183 | 10 | C0376358 | |
| Disease | hemoglobin A1 measurement | 5.36e-03 | 520 | 183 | 9 | EFO_0007629 | |
| Disease | disease free survival | 5.48e-03 | 18 | 183 | 2 | EFO_0000409 | |
| Disease | fibrinogen measurement, factor VII measurement | 5.64e-03 | 58 | 183 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | myeloid white cell count | DNAJC13 HSP90B2P CDH23 COLGALT1 RUNX2 USP8 GUCY1B1 MAP4K5 SBF2 PKN2 DTHD1 FBXO34 DNMT1 | 5.85e-03 | 937 | 183 | 13 | EFO_0007988 |
| Disease | Carcinoma, Granular Cell | 5.98e-03 | 116 | 183 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.98e-03 | 116 | 183 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.98e-03 | 116 | 183 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.98e-03 | 116 | 183 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.98e-03 | 116 | 183 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.98e-03 | 116 | 183 | 4 | C0001418 | |
| Disease | electrocardiography | 6.05e-03 | 530 | 183 | 9 | EFO_0004327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRHIKRPEGRKPSEV | 116 | Q7L4P6 | |
| RPEGRKPSEVAHKSI | 121 | Q7L4P6 | |
| IPAEGIKSNPSKRHR | 26 | P35869 | |
| IRNKIHRLPVIDPES | 146 | P54619 | |
| DNPGVRRHLVKKPSR | 276 | P48751 | |
| SQHQVPVLREKPKRV | 236 | A0A096LP49 | |
| PRPSKLHNSKVNRRE | 296 | Q9NXE8 | |
| RDLRTPKHKVSEQRP | 166 | O75638 | |
| TGLTRHPEEKPVRKD | 161 | Q8TDX6 | |
| HRSQPKDLAAKRRPE | 286 | P26358 | |
| KEHIEIIAPSPQRSR | 706 | Q9NZJ5 | |
| GRTSHIPVQQPEKRK | 501 | Q6L9W6 | |
| RPRSVHEKRVPQEQA | 266 | O60242 | |
| LFHPEQNVPKRKRSL | 846 | Q14833 | |
| KKEHPPEVSRETQRT | 11 | Q9NWN3 | |
| KHRIISPKVEPRALT | 246 | O94983 | |
| KPPSNERIILHAIES | 231 | Q96DT5 | |
| DDDPQIHHPRKRKVS | 1776 | Q6UB98 | |
| RQPEAHEKPSQKRVK | 651 | Q9P1Z9 | |
| EEPGEKRPKFHLNIR | 51 | Q9NSV4 | |
| AAKEKVRRRHTPAPT | 46 | Q2NKX9 | |
| DRGTPPRKKDHILQV | 1501 | Q9H251 | |
| ARKKQDPPVTHDLRV | 156 | P25685 | |
| VREIKRIHFSPSEPK | 596 | Q8IZT6 | |
| THKIIAPANLERPVR | 121 | Q9NYB9 | |
| DPAKRITLREALKHP | 461 | P49759 | |
| IPRKLVSHKPLNDRS | 96 | Q8N123 | |
| AKEPRSPVITRKHVL | 341 | Q6P387 | |
| VLAKRDAEIPRHVPK | 146 | Q5JR59 | |
| PHKVDGRVVEPKRAV | 76 | Q32P51 | |
| PHKVDGRVVEPKRAV | 31 | A0A2R8Y4L2 | |
| KPEDVHTSHPLKQRR | 351 | Q5RL73 | |
| PRKLDHKEPDCRTVR | 356 | Q4KMZ1 | |
| RDSLPPRVKDLHKVS | 656 | Q9P286 | |
| SKADRKPFIPQIDHI | 741 | Q5KSL6 | |
| ELKPEQETTPRHKQE | 481 | Q9H4G0 | |
| KKTFEINPRHPLIRD | 321 | Q58FF3 | |
| EHSAPAKVVRAAVPK | 146 | Q6PKG0 | |
| AKELRAVEDVRPPHK | 746 | O95819 | |
| TKVEVPKRHPDRVEK | 3946 | Q86XX4 | |
| PKRHPDRVEKNVNRH | 3951 | Q86XX4 | |
| PAKEENPRRASKAVE | 126 | Q9BW71 | |
| VLKAQLHKRPEVDSP | 1731 | Q9BY89 | |
| TLEDHPNIKRVTPQR | 116 | Q14703 | |
| PVSKHKLPNQGEDRR | 81 | Q9BQP7 | |
| EAVHRESRRLPPIQK | 856 | Q86WG5 | |
| VREVKDKHPDLPLAV | 261 | P13716 | |
| KLPKQARDDLPRHIS | 31 | P48051 | |
| KKARRDQTPKAVPQH | 376 | A9Z1Z3 | |
| RQKHPPATLEAIIRE | 981 | Q9BY66 | |
| HRLEKIPEPIKEATA | 466 | Q13948 | |
| ASVVREHVDKLKIPP | 166 | Q9Y6G9 | |
| EHVRKALQSPISPIR | 346 | Q8N3T1 | |
| PDSPQRREKLHKVAP | 526 | Q99259 | |
| RDPVSTRVKLKIVPH | 326 | Q5VYK3 | |
| KLERSAPKPRLEHQK | 176 | Q8N140 | |
| HRPLDKKREEAPSLR | 46 | P02675 | |
| RIHPEVDPSVITKLR | 311 | Q8IZT8 | |
| IVPNHEKRAGKLEPR | 696 | Q7Z406 | |
| LQAPRERASEPKHKN | 206 | Q96S96 | |
| EEISKQHPKAITPRR | 281 | Q6N069 | |
| IFPNSVKVPQRKHVR | 61 | Q8WU58 | |
| KRTNIIPVIEDARHP | 206 | P22087 | |
| IRHKFPINVLPKDDS | 506 | Q5H8C1 | |
| EREKNSAPPHRRAQK | 491 | Q14005 | |
| RKRKHLPDRQDGPAA | 331 | Q92917 | |
| NEDHRKVRRTTPVPL | 161 | Q9BRS8 | |
| EQDVNHPKPAKRART | 216 | Q68G74 | |
| KRKRELQQHEGFPPA | 176 | O96004 | |
| SVLPPSVANELRHKR | 396 | Q02153 | |
| SVANELRHKRPVPAK | 401 | Q02153 | |
| PEIQRALRAPRKKIH | 296 | P36578 | |
| HDPSVRPSVDEILKK | 451 | Q8NB16 | |
| PVTRKPRIHEAQFIK | 131 | A6NMN3 | |
| KPIEVEHSVPKRQRI | 66 | O00425 | |
| SPKEEVKLEAHIRVP | 481 | O00425 | |
| RSKTIVQLKPRSPDH | 851 | Q9UPN3 | |
| VPEVQRRIQKKGDPH | 211 | O95299 | |
| DPKEIDIPRHGTKNR | 406 | Q15256 | |
| TIRTRKPLDHETQPV | 931 | Q6V1P9 | |
| EPKVVFAKEQPAHRE | 1621 | Q5VST9 | |
| KILPDTQRHVKSPRT | 686 | Q9Y5I4 | |
| EKPVHLPVLRRSKSQ | 611 | Q96MT3 | |
| RHVVKDKLPSLFPDQ | 441 | Q3MJ16 | |
| CKTDPQREPKGILRH | 1871 | Q96QU1 | |
| EHRPKEKRVTLLTPA | 6 | Q9BZI7 | |
| SKIQREPPEVHRANI | 346 | A2A2Y4 | |
| SAKIKREPPEIHRAG | 331 | Q7Z6J6 | |
| TQEAPVKEKHARRII | 41 | O75146 | |
| RPEKVQSAKLEHLRP | 866 | Q9Y2F5 | |
| SAHNPDDIKPRRIRK | 246 | O15234 | |
| KPLVKEGADRPRQIH | 571 | Q7Z5Q1 | |
| PPSTENKHEAKRRRT | 51 | Q6PH81 | |
| LPRPQDLKLRDVTHS | 1566 | Q99715 | |
| EHQRVQQRKESKKPP | 31 | Q9UBU3 | |
| KSHKALSKEENRRPP | 296 | Q14241 | |
| LAPVFTKDEQKHRRP | 2166 | Q8TD26 | |
| RPNKPAELIAKHVDS | 401 | Q13619 | |
| DIIHTPQIRKARPQK | 101 | Q86WZ0 | |
| EAKRHRPLIALPTQD | 151 | P01344 | |
| EQIPKPHVIVKRTDE | 61 | Q7Z4T8 | |
| ITANEDPPVISKRRH | 576 | Q5VT06 | |
| ARPVPKHIREALQNV | 36 | Q9HBK9 | |
| PQRPRKRLTEQELHD | 356 | Q96GE4 | |
| VPPKHRELRVTKRNI | 396 | Q6QEF8 | |
| KDNPHRIAVLVVPSK | 516 | Q6ZMT9 | |
| QKISPRHSEPVKRVL | 241 | O75165 | |
| RPHVVKRPKSNIAVE | 501 | Q8TEH3 | |
| HLEQRQVKVEEPSRP | 211 | Q08050 | |
| RVDGVREKSDPHIKL | 181 | P09038 | |
| AQAAPPRDLDKKRHA | 61 | Q68CP4 | |
| LLQKRSRPEAVSHPL | 26 | Q00013 | |
| IPSPSHLQLDTRREK | 4091 | Q8NDH2 | |
| IVPEHDVSRIIKKPD | 6246 | Q8NDH2 | |
| IVDEAHRIKNPKARV | 281 | Q5T890 | |
| HPEKAVPRVRNLVEA | 476 | Q8NBJ5 | |
| HIPIQVIRKEVDSKP | 336 | O95817 | |
| PRTVIHPKARIIAEA | 31 | O00399 | |
| PDILTKRKLHREPIQ | 911 | Q9P225 | |
| TKVPISHNKRDRDLP | 16 | Q8N7B9 | |
| GVRTHERRPTNKEPK | 106 | Q6W0C5 | |
| KSKGRTHPRIDPDVI | 411 | Q9Y661 | |
| HRVPTQRRPSQFDKK | 61 | Q5T6X4 | |
| KKRHQPAPVKLRESV | 376 | Q659C4 | |
| IESPSERRKKSPREH | 971 | Q9UPQ0 | |
| NPKKRPTAERLLTHT | 261 | Q9Y4K4 | |
| HRLVVLVKDNGEPPR | 636 | Q9Y5E3 | |
| KLASQEHREPKRPEI | 116 | O43196 | |
| KRLPPLKEKQHARAA | 621 | A6NNL0 | |
| KRLPPLKEKQHSRAA | 621 | B1AL46 | |
| VRDEKRGKRPSPLAH | 1471 | Q9NQT8 | |
| PRRHRQKLDDQTKPG | 176 | Q01196 | |
| EPRRHRQKLDDSKPS | 226 | Q13950 | |
| RRHRQKLEDQTKPFP | 181 | Q13761 | |
| IRKVHPDSKAPVIIV | 131 | Q6T310 | |
| IKVHEPPRKIERFTL | 106 | P82664 | |
| KPPRLSEIKRKTDEH | 996 | Q2M3C7 | |
| HPRRLKVKPDSEILV | 926 | A6NHR9 | |
| KERGPKPEHRQSKVE | 126 | Q6ZQX7 | |
| NIEKELPKPRHVFRR | 296 | Q9C0I9 | |
| INRVHDPVTAKPKLV | 276 | P13995 | |
| HRPGLKISKREEVEA | 61 | Q92901 | |
| PLAVHDEAEKRLPKA | 651 | P22670 | |
| TNSVEERKDVKPHPR | 1646 | Q9HCM1 | |
| ERKDVKPHPRKEQAP | 1651 | Q9HCM1 | |
| HVKEPERRGPQKRLA | 336 | Q9Y2Z4 | |
| KDKRICPDRHRINPE | 851 | Q587J7 | |
| PVLQERLHTKDKVPD | 26 | P58743 | |
| KLEKPRPSVSHGRAQ | 396 | Q5T2S8 | |
| SKKERRPVRPHTVEK | 806 | Q5JRX3 | |
| TRENKGQKLEPIPHR | 456 | Q8NDZ2 | |
| TQDHKPCNPREKERI | 166 | O75688 | |
| SPHPIRITKTVDRKD | 826 | Q2KHM9 | |
| EVPKNHPKSRIIIEE | 281 | Q16513 | |
| DRDKLRIPPTTHQAL | 161 | Q8NA69 | |
| LSDELKPAHRKRELP | 241 | Q9UBF8 | |
| HVRSKNRDFSLPVPK | 66 | O15047 | |
| AKKEPRFQEKPDRRH | 331 | Q12765 | |
| RVQIHDTRPVKPELA | 746 | Q86XI2 | |
| KEKHIEPEVPRTSRD | 151 | Q9Y2B4 | |
| ELKEHPEAPVQRRQK | 71 | Q96Q45 | |
| EIKRRGKDPTEHIPE | 231 | Q9H9Y2 | |
| KVIPQSRVAKPHQRE | 91 | Q9H4B4 | |
| ETTNRPRKAKIRHPV | 21 | Q96ET8 | |
| PEPEREQKRRKIDTH | 1401 | Q8NI27 | |
| KELNDRFRHKIPVPI | 286 | O43511 | |
| SVKISPKGVPNEHRR | 576 | Q9BW04 | |
| PKGVPNEHRREALKK | 581 | Q9BW04 | |
| NAEKPHSIVDPLVRI | 676 | Q8N3E9 | |
| SRKPAHPVKREINEE | 16 | A7XYQ1 | |
| HPRKVRESRQAPNKL | 11 | Q96IC2 | |
| NPELVRKSFKVHVPI | 656 | Q6ZQQ2 | |
| IRDHEVLFPKSKDIP | 346 | P42331 | |
| KQLEPPKEGERRTTH | 321 | Q12772 | |
| LKRREKPQQSPAIEH | 231 | P58340 | |
| HSDIVQSLPPDLRRK | 276 | Q8WWY3 | |
| RPPLHKKRVEDESLD | 1081 | Q8WVM7 | |
| KRPAPRTAPRQEKHE | 61 | O43609 | |
| KSQPVTPEKHRARKR | 366 | P54274 | |
| RPHKVDGRVVEPKRA | 96 | P51991 | |
| PEEDPERTKHRRKQK | 411 | Q96KM6 | |
| KAEHREREPPSIKTD | 581 | Q13061 | |
| RIQHDQPVKPLDRAV | 446 | P36537 | |
| TEPKERKRAHIGVIP | 226 | Q6NXT6 | |
| KHQEEPEKPSRNPER | 126 | Q9Y2Y4 | |
| RRPPTRVHLKEVASA | 151 | Q8TD55 | |
| ETTNRPRKAKIRHPV | 21 | Q9NYZ1 | |
| REAKVPHLPADKARG | 296 | P20333 | |
| SAKKDRLPRNIHVPE | 146 | O15050 | |
| PHKVDGRVVEPKRAV | 76 | P09651 | |
| RILAKQKIHPERTPS | 111 | Q9NRG4 | |
| RKHKEQCNPETRPVE | 36 | Q15649 | |
| HGSSPEQVVRPKVRK | 306 | O43164 | |
| SERKDHRPETPSIKQ | 1031 | Q9NYI0 | |
| HKAKPQIPAERDREP | 696 | P40818 | |
| HAVRLGPQEEKRIPI | 551 | O95932 | |
| SPENEPDLKKRIRVH | 741 | Q15386 | |
| VPSKIDEKRLTPRHI | 746 | Q5T7N2 | |
| LRHTIIPAKSPEKCR | 1906 | Q9NZM1 | |
| KHATAISDPPELKRV | 631 | O76041 | |
| PDLPEVKRVKETQKH | 6196 | P20929 |